Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer

NCT06292988 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT06292988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Observational
Overall status
Completed
Start date
March 1, 2024
Completion date
April 15, 2024
Enrollment
500 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

medullary thyroid cancer